Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Cash from Investing Activities (2016 - 2025)

Wave Life Sciences (WVE) has disclosed Cash from Investing Activities for 11 consecutive years, with $1000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Investing Activities rose 101.16% year-over-year to $1000.0, compared with a TTM value of -$718000.0 through Dec 2025, up 23.45%, and an annual FY2025 reading of -$718000.0, up 23.45% over the prior year.
  • Cash from Investing Activities was $1000.0 for Q4 2025 at Wave Life Sciences, up from -$248000.0 in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $24.8 million in Q4 2022 and bottomed at -$50.2 million in Q1 2022.
  • Average Cash from Investing Activities over 5 years is -$229300.0, with a median of -$181500.0 recorded in 2023.
  • Peak annual rise in Cash from Investing Activities hit 165700.0% in 2022, while the deepest fall reached 46388.89% in 2022.
  • Year by year, Cash from Investing Activities stood at -$15000.0 in 2021, then skyrocketed by 165700.0% to $24.8 million in 2022, then crashed by 101.43% to -$356000.0 in 2023, then surged by 75.84% to -$86000.0 in 2024, then surged by 101.16% to $1000.0 in 2025.
  • Business Quant data shows Cash from Investing Activities for WVE at $1000.0 in Q4 2025, -$248000.0 in Q3 2025, and -$306000.0 in Q2 2025.